SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001078782-17-000271
Filing Date
2017-03-01
Accepted
2017-02-28 18:58:05
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D/A1 f13da1022117_sc13dz.htm SC 13D/A 30613
  Complete submission text file 0001078782-17-000271.txt   32288
Mailing Address 18 E. 50TH STREET 5TH FLOOR NEW YORK NY 10022
Business Address 18 E. 50TH STREET 5TH FLOOR NEW YORK NY 10022 (212) 751-0001
AXIM BIOTECHNOLOGIES, INC. (Subject) CIK: 0001514946 (see all company filings)

IRS No.: 274092986 | State of Incorp.: NV | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-88107 | Film No.: 17650551
SIC: 2834 Pharmaceutical Preparations

Mailing Address 12255 CROSTHWAITE CIRCLE POWAY CA 92064
Business Address 12255 CROSTHWAITE CIRCLE POWAY CA 92064 858-859-7638
Medical Marijuana Inc (Filed by) CIK: 0001604964 (see all company filings)

IRS No.: 000000000 | State of Incorp.: OR | Fiscal Year End: 1231
Type: SC 13D/A